Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. AMGN Shows Gap Up in Shares - Optimal Time to Buy

December 26, 2024
Amgen Inc. (NASDAQ:AMGN) has recently experienced a significant gap up in its shares, indicating a favorable time to make an investment. This biotech giant is well-positioned in the market, making it one of the best dividend stocks to consider. With a strong track record of delivering consistent returns and a solid financial standing, Amgen offers stability and growth potential for investors.

Amidst recent market volatility, Amgen has maintained its resilience and outperformed competitors. The company has successfully navigated challenges and is set to deliver impressive results. It continues to invest in research and development, focusing on innovative treatments for various diseases.

Analysts predict a positive outlook for Amgen Inc., and expert opinions suggest that its stock is expected to rise. Considering the company's robust pipeline and promising drugs in development, investors are advised to seize this opportunity and purchase Amgen shares before December 23rd.

For reliable stock forecasts and insights on Amgen Inc. and other companies, it is recommended to consult professionals in Stocks Prognosis. They can provide expert guidance and help investors make informed decisions, maximizing their potential for profitable returns.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


AMGNDecember 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years  ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....


GSKJanuary 5, 2025GSK Plc's Strong Returns and Updates on Voting Rights and Capital Structure  ~1 min.

GSK plc, a leading pharmaceutical company, continues to deliver strong returns to its shareholders....


AMGNJanuary 14, 2025Amgen Inc. Continues to be a Top Value Stock for the Long-Term  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has consistently proven itself as a top value stock for long-term investors....


NIFebruary 26, 2025NiSource Inc. - A Promising Investment Opportunity for Long Term Investors  ~1 min.

Despite a trailing one-year earnings growth, NiSource Inc. (NYSE:NI) remains an attractive choice for long term investors....


AMGNDecember 26, 2024Amgen Inc. Continues to Attract Investors: Promising Outlook for AMGN  ~2 min.

Leading biotechnology company Amgen Inc. (NASDAQ:AMGN) has caught the attention of investors with its solid performance and positive market trends. In recent news, Principal Financial Group Inc....